Unlabelled: Sino-nasal malignancies are extremely rare accounting < 1% of all malignancies and < 3% of aero-digestive tract tumors. Their surgical pathology is extremely challenging due to the enormous heterogeneity. Few of these sino-nasal tumors may possibly present histologically as clear cell neoplasm. This mechanism is described as 'histological mimicry'. Renal cell-like adenocarcinoma (RCLA) is amongst the top contenders in that list of tumors including squamous cell carcinoma and mucoepidermoid carcinoma. RCLA affecting the nasal cavity is an extremely rare malignancy to have been reported in the literature. It was first described by Zuhr et al. in 2002 and till as recent as 2017 only 15 such cases had been reported worldwide. We present a rare case report of a 45 years old female who presented with unilateral nasal obstruction but was found harboring a histopathological surprise. We wish to highlight the diagnostic and therapeutic challenge faced in the management of this case and create awareness amongst the ORLs, pathologists and medical oncologists about this unaccustomed entity.
Supplementary Information: The online version contains supplementary material available at 10.1007/s12070-024-05275-6.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890666 | PMC |
| http://dx.doi.org/10.1007/s12070-024-05275-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Renal Cell-Like Adenocarcinoma of Nasal Cavity: A Rare Entity Deserving Elucidation.
Indian J Otolaryngol Head Neck Surg
February 2025
Department of ENT, Command Hospital- Eastern Command, Kolkata, India.
Unlabelled: Sino-nasal malignancies are extremely rare accounting < 1% of all malignancies and < 3% of aero-digestive tract tumors. Their surgical pathology is extremely challenging due to the enormous heterogeneity. Few of these sino-nasal tumors may possibly present histologically as clear cell neoplasm.
View Article and Find Full Text PDFCase Report of a Primary Sinonasal Renal Cell-Like Adenocarcinoma With Gene Rearrangement in a 13-Year-Old Male.
Ear Nose Throat J
February 2025
Department of Pathology, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.
Background: Sinonasal renal cell-like adenocarcinoma (SNRCLA) is a rare, low-grade malignant neoplasm originating in the nasal cavity and paranasal sinuses. This report provides a detailed account of the clinical and pathological characteristics of a single case of SNRCLA, highlights its differential diagnosis, and includes a review of relevant literature.
Case Description: A 13-year-old male presented with a mass in the right nasal cavity.
SENP3-FIS1 axis promotes mitophagy and cell survival under hypoxia.
Cell Death Dis
December 2024
School of Biosciences, University of Sheffield, Firth Court, Western Bank, Sheffield, S10 2TN, UK.
SUMOylation, the covalent attachment of the small ubiquitin-like modifier (SUMO) to target proteins, and its reversal, deSUMOylation by SUMO proteases like Sentrin-specific proteases (SENPs), are crucial for initiating cellular responses to hypoxia. However, their roles in subsequent adaptation processes to hypoxia such as mitochondrial autophagy (mitophagy) remain unexplored. Here, we show that general SUMOylation, particularly SUMO2/3 modification, suppresses mitophagy under both normoxia and hypoxia.
View Article and Find Full Text PDFA Multi-Omics Prognostic Model Capturing Tumor Stemness and the Immune Microenvironment in Clear Cell Renal Cell Carcinoma.
Biomedicines
September 2024
Department of Urology, Changhai Hospital, Navel Medical University (Second Military Medical University), Shanghai 200433, China.
Cancer stem-like cells (CSCs), a distinct subset recognized for their stem cell-like abilities, are intimately linked to the resistance to radiotherapy, metastatic behaviors, and self-renewal capacities in tumors. Despite their relevance, the definitive traits and importance of CSCs in the realm of oncology are still not fully comprehended, particularly in the context of clear cell renal cell carcinoma (ccRCC). A comprehensive understanding of these CSCs' properties in relation to stemness, and their impact on the efficacy of treatment and resistance to medication, is of paramount importance.
View Article and Find Full Text PDFGLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy.
Mol Ther
July 2024
Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:
The tumor microenvironment presents many obstacles to effective chimeric antigen receptor (CAR) T cell therapy, including glucose competition from tumor and myeloid cells. Using mouse models of acute lymphoblastic leukemia (ALL), renal cell carcinoma (RCC), and glioblastoma (GBM), we show that enforced expression of the glucose transporter GLUT1 enhances anti-tumor efficacy and promotes favorable CAR-T cell phenotypes for two clinically relevant CAR designs, 19-28z and IL13Rα2-BBz. In the NALM6 ALL model, 19-28z-GLUT1 promotes T stem cell-like memory formation and prolongs survival.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!